跳至主要内容
临床试验/CTRI/2022/11/047197
CTRI/2022/11/047197尚未招募2 期

Efficacy of Jyotishmati Taila Nasya in the management of Vataja Shirashula w.s.r to Tension Type of Headache - A double blinded randomised clinical trail.

Dr Shradha Rao1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2022年11月20日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Headache Disability Index

研究概览

简要总结

With the rapid changes in the modern lifestyles - bad food habits, physical inactivity, wrong body posture, and disturbed biological clock, stressful and competitive times. 21st century being known as the competitive yuga adds up more to the psychosomatic disorders. Headache disorders being extraordinarily common, tension type of headache prevalence had rised upto 82% among the primary headache forms . Tension-Type Headache (TTH) are more disabling and shows more missed works than migraine . Recent studies have shown a worldwide lifetime prevalence of 46% to 78% of tension type headache . Comparing this with Vataja Shirashula mentioned in Ayurveda having similar signs and symptoms and mental factors mentioned attributing to its aetiopathogenesis, according to Acharya Charaka. Nasya being the best form for administration of medicines in all urdhwa jatrugata vikaras . Considering all this Jyotishmati Taila Nasya which has medhya and vedana shamaka karma with classical reference from Raj Nighantu, ksheeradi varga. Also studies conducted on jyotishmati proves its antinociceptive and anti-inflammatory properties , So this study has been planned.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Participant and Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • a Patients presenting with classical sypmtoms of Vataja Shira Shula and TTH b Nasya Yogyas.

排除标准

  • a Nasya Ayogya Migraine and Cluster headache any pathology involving in eyes ENT infections b Secondary headache arising due to meningitis tumour cervical spondylosis etc c Pregnant lactating females old aged d With major psychomotor disturbances eg suicidal tendencies extreme cases of depression.

结局指标

主要结局

Headache Disability Index

时间窗: Baseline 7th day and 15th day

Grading for Photophobia

时间窗: Baseline 7th day and 15th day

Headache Duration and Frequency Grading

时间窗: Baseline 7th day and 15th day

Visual Analogue Scale

时间窗: Baseline 7th day and 15th day

次要结局

未报告次要终点

研究者

发起方
Dr Shradha Rao
申办方类型
Other [Self ]

研究点 (1)

Loading locations...

相似试验